Page last updated: 2024-08-23

dermatan sulfate and Nephritis

dermatan sulfate has been researched along with Nephritis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Belmiro, CL; Gonçalves, RG; Kozlowski, EO; Leite, M; Pavão, MS; Takyia, CM; Werneck, AF	1

Other Studies

1 other study(ies) available for dermatan sulfate and Nephritis

Article	Year
Dermatan sulfate reduces monocyte chemoattractant protein 1 and TGF-β production, as well as macrophage recruitment and myofibroblast accumulation in mice with unilateral ureteral obstruction. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 2011, Volume: 44, Issue:7 Topics: Animals; Anti-Inflammatory Agents; Chemokine CCL2; Dermatan Sulfate; Disease Models, Animal; Fibrosis; Injections, Subcutaneous; Kidney; Macrophage Activation; Macrophages; Male; Mice; Myofibroblasts; Nephritis; Transforming Growth Factor beta; Ureteral Obstruction	2011

Article

Year

Dermatan sulfate reduces monocyte chemoattractant protein 1 and TGF-β production, as well as macrophage recruitment and myofibroblast accumulation in mice with unilateral ureteral obstruction.

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 2011, Volume: 44, Issue:7

Topics: Animals; Anti-Inflammatory Agents; Chemokine CCL2; Dermatan Sulfate; Disease Models, Animal; Fibrosis; Injections, Subcutaneous; Kidney; Macrophage Activation; Macrophages; Male; Mice; Myofibroblasts; Nephritis; Transforming Growth Factor beta; Ureteral Obstruction

2011